Lee Ainslie Bio Techne Corp Transaction History

Maverick Capital LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $591,096 - $687,096	-1,526 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $207,649 - $271,260	-660 Reduced 30.19%	1,526 $583,000
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $365,165 - $476,045	1,479 Added 209.19%	2,186 $694,000
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $73,845 - $89,981	318 Added 81.75%	707 $175,000
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $1.49 Million - $2.24 Million	-8,019 Reduced 95.37%	389 $103,000
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $132,320 - $181,859	-821 Reduced 8.9%	8,408 $1.59 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $1.75 Million - $2.05 Million	9,229 New	9,229 $2.03 Million

598

152M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.82B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.